Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,180.6
38.9 (1.24%)

 

  • STI Straits Times Index
    3,180.6
    38.9 (1.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.9
    -2.5 (-0.16%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,315.3
    841.4 (3.30%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,411.7
    50.1 (1.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,782.4
    200.8 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,120.7
    32.2 (0.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,159.2M
  • Value: 1,470.4M
  • Rise: 205
  • Fall: 137
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
GKE0.153-0.008
Golden Agri-Res0.235+0.020
CapAllianz0.003-
Abundance Intl0.042-
Singtel2.280+0.050
Shen Yao0.007+0.001
RH PetroGas0.182+0.010
ISDN0.780+0.070
Sembcorp Marine0.108-0.002
Geo Energy Res0.260+0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,778.3 +15.7
HSI 26,315.3 +841.4
HSCEI 9,415.7 +344.6
Jakarta 6,120.7 +32.2
Nikkei 225 27,782.4 +200.8
SSE Comp 3,411.7 +50.1
Shanghai A 3,575.8 +52.6
Shanghai B 256.1 +1.6
KOSPI 3,242.7 +5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GENMAB AS SPON ADS EACH REP 0.1 ORD SHS GENMAB A/S SPONSORED ADR
Updated on 28 Jul 2021 (End of trading day)
Last (USD): 44.740 Change: +0.690 High: 44.970 Remarks: -
Change (%): +1.57 Low: 43.820
Open 43.890 Yesterday's Close 44.050000000000004
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 271,435 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.10799 Trailing EPS (USD) e 1.29830 NAV (USD) b 4.8358
PE a 40.379 Trailing PE f 34.460 Price / NAV b 9.2518
Dividend (USD) d - Cash In Hand (USD) g 1.8992 Issued & Paid-up Shares c 656,687,000
Dividend Yield (%) d - Price / Cash In Hand g 23.557 Treasury Shares h 2,029,770
Market Cap (M) 29,380.176 Enterprise Value (M) 26,582.271
Piotroski F Score 6 Exchange Code GMAB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 36.76 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Jul 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 07 May 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,380.176 40.379 34.460 9.2518 -
Industry Medical Specialties NASDAQ 3,471.654 169.324 143.661 9.8978 0.024
Local Peer INTUITIVE SURGICAL INC NASDAQ 115,482.430 108.884 71.171 10.6558 -
Local Peer IDEXX LABORATORIES INC NASDAQ 59,319.549 101.963 87.984 84.4171 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 49,212.677 27.712 107.420 14.5017 -
Local Peer DEXCOM INC NASDAQ 44,476.978 90.107 86.531 23.3696 -
Local Peer NOVOCURE LTD NASDAQ 18,812.893 949.776 1,604.101 50.5544 -
Local Peer INSULET CORPORATION NASDAQ 18,670.505 2,745.693 2,097.810 31.8990 -
Local Peer HOLOGIC INC NASDAQ 18,469.275 16.561 9.684 4.8675 -
Local Peer ABIOMED INC NASDAQ 14,682.711 65.105 65.105 11.0423 -
Local Peer MASIMO CORPORATION NASDAQ 14,571.359 60.638 84.006 - -
Local Peer DENTSPLY SIRONA INC NASDAQ 14,225.601 - 81.803 2.8873 0.615
Local Peer BRUKER CORPORATION NASDAQ 12,344.416 78.228 60.512 12.7564 0.197
Local Peer TANDEM DIABETES CARE INC NASDAQ 6,548.166 - - 20.8930 -
Other Local Peers SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), HESKA CORP (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), VERICEL CORP (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SIGHT SCIENCES INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), EARGO INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), 908 DEVICES INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), ZYNEX INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), NEUROPACE INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SIENTRA INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCIRA HEALTH INC (NASDAQ), CVRX INC (NASDAQ), NEURONETICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), QUOTIENT LTD (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), IRIDEX CORP (NASDAQ), NEUROMETRIX INC (NASDAQ), CELSION CORPORATION (NASDAQ), LENSAR INC (NASDAQ), AVINGER INC (NASDAQ), NEPHROS INC (NASDAQ), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIREMD INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 214,142.346 47.874 33.718 - 1.266
Global Peer DANAHER CORP NYSE 209,087.032 59.569 59.569 5.2949 0.245
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 207,624.902 32.569 26.202 5.9223 0.168
Global Peer MEDTRONIC PLC NYSE 175,405.828 48.643 48.643 3.4107 1.779
Global Peer STRYKER CORP NYSE 101,224.653 63.305 67.890 - 0.875
Global Peer BECTON DICKINSON & CO NYSE 73,716.800 96.111 44.949 2.9696 1.259
Global Peer EDWARDS LIFESCIENCES CORP NYSE 68,417.368 83.091 80.396 14.6868 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,551.941 - 218.081 - -
Global Peer AGILENT TECHNOLOGIES INC NYSE 45,959.477 63.921 49.686 9.5550 0.480
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,741.654 30.848 31.159 2.9450 2.240
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), ANGELALIGN (HKEx), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), CARDIOFLOW-B (HKEx), EBOS GROUP (ASX), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), LIFETECH SCI (HKEx), GLAUKOS CORPORATION (NYSE), SUPERMX (Bursa), ZYLOXTB-B (HKEx), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), NANOSONICS LIMITED (ASX), CIRC (HKEx), CRYOLIFE INC (NYSE), CHUNLI MEDICAL (HKEx), MODERN DENTAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), BASECARE-B (HKEx), VAPOTHERM INC (NYSE), MCP INCOME OPPORTUNITIES TRUST (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), Medtecs Intl (SGX), AROA BIOSURGERY LTD (ASX), PW MEDTECH (HKEx), UGHealthcare (SGX), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), INCANNEX HEALTHCARE LTD (ASX), ALPHA PRO TECH (NYSE American), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), KELFRED (HKEx), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), MICRO-X LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ELECTROMED INC (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), OPTISCAN IMAGING (ASX), CLEANSPACE HOLDINGS LTD (ASX), VOLITIONRX LIMITED (NYSE American), SDI LTD (ASX), ADVENTA (Bursa), MILESTONE SCIENTIFIC INC (NYSE American), YUNNAN ENERGY (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), RGTBHD (Bursa), RESONANCE HEALTH LTD (ASX), COMPUMEDICS (ASX), Biolidics (SGX), CARDIEX LTD (ASX), LKL (Bursa), DIMERIX LTD (ASX), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), Yunnan Energy (SGX), NOVA EYE MEDICAL LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), USCOM LTD (ASX), METALICITY LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.380
+0.86 %
10 Days -+1.620
+3.76 %
20 Days -+3.190
+7.68 %
Medium Term Return 3 Months -+7.460
+20.01 %
6 Months -+4.540
+11.29 %
1 Year -+9.720
+27.76 %
Long Term Return 2 Years -+26.290
+142.49 %
Annualised Return Annualised --
+55.72 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 30.100 - 45.210 Change From 1 Year Low +14.640 % Change From 1 Year Low (%) +48.64
Change From 1 Year High -0.470 % Change From 1 Year High (%) -1.04
2 Years Range 16.240 - 45.210 Change From 2 Years Low +28.500 % Change From 2 Years Low (%) +175.49
Change From 2 Years High -0.470 % Change From 2 Years High (%) -1.04
5 Years Range 16.240 - 45.210 Change From 5 Years Low +28.500 % Change From 5 Years Low (%) +175.49
Change From 5 Years High -0.470 % Change From 5 Years High (%) -1.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jul 2021 43.890 44.970 43.820 44.740 271,435 -
27 Jul 2021 44.110 44.150 43.620 44.050 245,873 -
26 Jul 2021 44.560 44.560 44.050 44.080 275,588 -
23 Jul 2021 44.910 45.210 44.760 44.850 218,872 -
22 Jul 2021 44.530 44.710 44.321 44.360 256,028 -
21 Jul 2021 43.940 44.380 43.550 44.150 356,088 -
20 Jul 2021 43.100 43.820 42.765 43.780 556,636 -
19 Jul 2021 43.060 43.540 42.930 43.220 161,721 -
16 Jul 2021 43.370 43.586 43.060 43.220 337,140 -
15 Jul 2021 43.590 43.610 43.050 43.120 412,944 -
14 Jul 2021 43.530 43.530 43.150 43.210 287,524 -
13 Jul 2021 43.380 43.950 43.290 43.490 215,656 -
12 Jul 2021 44.390 44.450 43.810 43.830 259,026 -
09 Jul 2021 42.600 43.290 42.560 43.260 294,510 -
08 Jul 2021 42.560 42.860 42.270 42.770 244,293 -
07 Jul 2021 42.670 42.850 42.200 42.730 497,208 -
06 Jul 2021 41.970 42.110 41.500 41.970 235,728 -
02 Jul 2021 41.320 41.700 41.200 41.610 193,521 -
01 Jul 2021 40.732 41.600 40.619 41.550 384,384 -
30 Jun 2021 41.210 41.240 40.710 40.830 571,360 -
29 Jun 2021 41.730 41.730 41.440 41.460 260,425 -
28 Jun 2021 41.970 42.180 41.830 42.080 171,493 -
Summary
Current 2 Weeks
(15 Jul 2021 to 28 Jul 2021)
43.590 45.210 42.765 44.740 3,092,325 -
Previous 2 Weeks
(30 Jun 2021 to 14 Jul 2021)
41.210 45.210 40.710 43.210 3,183,210 -
4 Weeks from
(02 Jun 2021 to 29 Jun 2021)
40.210 45.210 39.960 41.460 15,829,847 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.